AstraZeneca/Daiichi Sankyo, BioNTech, Merus to Present Promising Cancer Therapies at ESMO Asia 2024
At the upcoming 2024 Asia Congress of the European Society for Medical Oncology, to be held this coming weekend in Singapore, AstraZeneca and Daiichi Sankyo will present consolidated data for their investigational antibody-drug conjugate datopotamab …